Irlandese

Immunity acquired from past COVID-19 infection provides strong, lasting protection against severe outcomes from the illness at a level “as high if not higher” than that provided by mRNA vaccines, according to a study published Thursday in The Lancet. Researchers conducted a systematic review and meta-analysis of 65 studies worldwide, providing overwhelming evidence to support what many scientists, doctors and studies have said since early in the COVID-19 pandemic. “The Lancet is finally acknowledging what doctors and scientists have been gaslit for saying for years — that natural immunity provides superior protection to experimental vaccines,” said Robert F. Kennedy, Jr., chairman and chief litigation counsel for Children’s Health Defense. “Only the tsunami of propaganda and censorship from the pharma/government biosecurity cartel and the controlled media persuaded the public that Pfizer and Moderna were better at protecting the human immune system than God and evolution,” he added. The study found that immunity acquired from infection was often far more robust and consistently waned more slowly than the immunity from two doses of an mRNA vaccine. The researchers found that natural immunity was at least 88.9% effective against severe disease, hospitalization and death for all COVID-19 variants 10 months after infection. It also provided 78.6% protection against reinfection for all variants except omicron BA.1, for which protection was 45.3%. At an October 2022 Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices meeting, the CDC presented data showing that vaccine-acquired immunity after two or three injections dropped to zero six months after injection, and then became negative. The Lancet study stated that “although protection from reinfection from all variants wanes over time, our analysis of the available data suggests that the level of protection afforded by previous infection is at least as high, if not higher than that provided by two-dose vaccination using high-quality mRNA vaccines (Moderna and Pfizer-BioNTech).”

Italiano

Immunity acquired from past COVID-19 infection provides strong, lasting protection against severe outcomes from the illness at a level “as high if not higher” than that provided by mRNA vaccines, according to a study published Thursday in The Lancet. Researchers conducted a systematic review and meta-analysis of 65 studies worldwide, providing overwhelming evidence to support what many scientists, doctors and studies have said since early in the COVID-19 pandemic. “The Lancet is finally acknowledging what doctors and scientists have been gaslit for saying for years — that natural immunity provides superior protection to experimental vaccines,” said Robert F. Kennedy, Jr., chairman and chief litigation counsel for Children’s Health Defense. “Only the tsunami of propaganda and censorship from the pharma/government biosecurity cartel and the controlled media persuaded the public that Pfizer and Moderna were better at protecting the human immune system than God and evolution,” he added. The study found that immunity acquired from infection was often far more robust and consistently waned more slowly than the immunity from two doses of an mRNA vaccine. The researchers found that natural immunity was at least 88.9% effective against severe disease, hospitalization and death for all COVID-19 variants 10 months after infection.It also provided 78.6% protection against reinfection for all variants except omicron BA.1, for which protection was 45.3%. At an October 2022 Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices meeting, the CDC presented data showing that vaccine-acquired immunity after two or three injections dropped to zero six months after injection, and then became negative. The Lancet study stated that “although protection from reinfection from all variants wanes over time, our analysis of the available data suggests that the level of protection afforded by previous infection is at least as high, if not higher than that provided by two-dose vaccination using high-quality mRNA vaccines (Moderna and Pfizer-BioNTech).”

ingleseitaliano.com | Usando il traduttore di testo Irlandese-Italiano?

Assicurati di rispettare le regole della scrittura e la lingua dei testi che tradurrai. Una delle cose importanti che gli utenti dovrebbero tenere a mente quando si utilizza il sistema di dizionario ingleseitaliano.com è che le parole e i testi utilizzati durante la traduzione sono memorizzati nel database e condivisi con altri utenti nel contenuto del sito web. Per questo motivo, ti chiediamo di prestare attenzione a questo argomento nel processo di traduzione. Se non vuoi che le tue traduzioni siano pubblicate nei contenuti del sito web, ti preghiamo di contattare →"Contatto" via email. Non appena i testi pertinenti saranno rimossi dal contenuto del sito web.


Norme sulla privacy

I fornitori di terze parti, tra cui Google, utilizzano cookie per pubblicare annunci in base alle precedenti visite di un utente al tuo o ad altri siti web. L'utilizzo dei cookie per la pubblicità consente a Google e ai suoi partner di pubblicare annunci per i tuoi utenti in base alla loro visita ai tuoi siti e/o ad altri siti Internet. Gli utenti possono scegliere di disattivare la pubblicità personalizzata, visitando la pagina Impostazioni annunci. In alternativa, puoi offrire agli utenti la possibilità di disattivare l'uso di cookie da parte di fornitori di terze parti per la pubblicità personalizzata, visitando la pagina www.aboutads.info.